Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Antibe Therapeutics Inc(Pre-Merger) ATBPF

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug, otenaproxesul, is in clinical development as an alternative to opioids and NSAIDs for acute pain. Its second pipeline drug, ATB-352, is being developed for a specialized pain indication. The Company also focuses on inflammatory bowel disease (IBD). Otenaproxesul combines a moiety that releases hydrogen sulfide with naproxen, a non-steroidal, anti-inflammatory drug. ATB-352 is an H2S-releasing derivative of ketoprofen, a potent NSAID commonly prescribed for acute pain. Its IBD candidates are being designed to maintain the efficacy, safety, and pharmacokinetic properties of ATB-429.


GREY:ATBPF - Post by User

Comment by Inthepezon Jul 13, 2021 12:02pm
157 Views
Post# 33535972

RE:RE:RE:AME study results

RE:RE:RE:AME study resultsI know you !diots lack imagination and think that “stonks go up”, so current SP can be explained like this:

most common shares are owned by retail. The retail shareholder is notorious for swing trades. Nothing on the horizon for ate. No catalysts for a few months and retail will lose interest, Opportunity cost wise, there are much better plays for retail investors. Fundamentals haven’t changed for this stock. 

The mental gymnastics to come up with a “leak scenario” is just dumb. 
StockingUp21 wrote:

how else can explain selling and lower every day? Something very wrong makes more sense then pumpers saying this is normal to lose 50% in couple months.

 

Inthepez wrote: They’re still underway. 4 more weeks to go. It’s uniformed people like you who panic sell. Idc if you do, but stop asking dumbass questions with leaks and nonsense. 

 

 



<< Previous
Bullboard Posts
Next >>